Publication:
Hidradenitis suppurativa and the metabolic syndrome

dc.contributor.authorERGUN, SAFİYE ATLAS TÜLİN
dc.contributor.authorsErgun, Tulin
dc.date.accessioned2022-03-12T22:24:32Z
dc.date.accessioned2026-01-11T17:47:15Z
dc.date.available2022-03-12T22:24:32Z
dc.date.issued2018
dc.description.abstractThe association of the metabolic syndrome (MetS) and its components with immune-mediated chronic inflammatory disorders has attracted much interest within the last two decades. In addition to the well-established association of psoriasis with MetS, recent data point to an association between MetS and hidradenitis suppurativa, as well. The association of hidradenitis suppurativa with MetS and its components, such as diabetes, obesity, and dyslipidemia, has been consistently identified in controlled studies. This relationship is not only limited to older individuals but also applicable to younger patients and those with mild disease. This review documents the link between these disorders and discusses its practical implications, mainly highlighting the importance of prevention and routine screening for early diagnosis to prevent cardiovascular-related morbidity. (C) 2018 Elsevier Inc. Ail rights reserved.
dc.identifier.doi10.1016/j.clindermatol.2017.09.007
dc.identifier.eissn1879-1131
dc.identifier.issn0738-081X
dc.identifier.pubmed29241751
dc.identifier.urihttps://hdl.handle.net/11424/234785
dc.identifier.wosWOS:000419087300007
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofCLINICS IN DERMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCARDIOVASCULAR-DISEASE
dc.subjectPREVALENCE
dc.subjectPSORIASIS
dc.subjectRISK
dc.subjectMORTALITY
dc.subjectARTHRITIS
dc.subjectLESIONS
dc.subjectACNE
dc.titleHidradenitis suppurativa and the metabolic syndrome
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage47
oaire.citation.issue1
oaire.citation.startPage41
oaire.citation.titleCLINICS IN DERMATOLOGY
oaire.citation.volume36

Files